Literature DB >> 30354505

Room With a View.

Lai-Ming Yung1, Paul B Yu1.   

Abstract

Entities:  

Keywords:  Editorials; endophenotypes; monocrotaline; oxidative phosphorylation; pulmonary circulation; vascular remodeling

Mesh：

Substances：

Year:  2018        PMID： 30354505      PMCID： PMC6309201          DOI： 10.1161/CIRCIMAGING.118.008148

Source DB:  PubMed          Journal:  Circ Cardiovasc Imaging        ISSN： 1941-9651            Impact factor:   7.792


× No keyword cloud information.
  24 in total

1.  Three-dimensional reconstruction of pulmonary arteries in plexiform pulmonary hypertension using cell-specific markers. Evidence for a dynamic and heterogeneous process of pulmonary endothelial cell growth.

Authors:  C D Cool; J S Stewart; P Werahera; G J Miller; R L Williams; N F Voelkel; R M Tuder
Journal:  Am J Pathol       Date:  1999-08       Impact factor: 4.307

2.  PulmoBind, an adrenomedullin-based molecular lung imaging tool.

Authors:  Myriam Létourneau; Quang Trinh Nguyen; François Harel; Alain Fournier; Jocelyn Dupuis
Journal:  J Nucl Med       Date:  2013-08-15       Impact factor: 10.057

3.  Enhanced [18F]fluorodeoxyglucose accumulation in the right ventricular free wall predicts long-term prognosis of patients with pulmonary hypertension: a preliminary observational study.

Authors:  Shunsuke Tatebe; Yoshihiro Fukumoto; Minako Oikawa-Wakayama; Koichiro Sugimura; Kimio Satoh; Yutaka Miura; Tatsuo Aoki; Kotaro Nochioka; Masanobu Miura; Saori Yamamoto; Manabu Tashiro; Yutaka Kagaya; Hiroaki Shimokawa
Journal:  Eur Heart J Cardiovasc Imaging       Date:  2014-01-09       Impact factor: 6.875

4.  Lung ¹⁸F-fluorodeoxyglucose positron emission tomography for diagnosis and monitoring of pulmonary arterial hypertension.

Authors:  Glenn Marsboom; Christian Wietholt; Chad R Haney; Peter T Toth; John J Ryan; Erik Morrow; Thenappan Thenappan; Peter Bache-Wiig; Lin Piao; Jonathan Paul; Chin-Tu Chen; Stephen L Archer
Journal:  Am J Respir Crit Care Med       Date:  2012-01-12       Impact factor: 21.405

Review 5.  A proposed mitochondrial-metabolic mechanism for initiation and maintenance of pulmonary arterial hypertension in fawn-hooded rats: the Warburg model of pulmonary arterial hypertension.

Authors:  Jalees Rehman; Stephen L Archer
Journal:  Adv Exp Med Biol       Date:  2010       Impact factor: 2.622

6.  Inhibition of pyruvate dehydrogenase kinase improves pulmonary arterial hypertension in genetically susceptible patients.

Authors:  Evangelos D Michelakis; Vikram Gurtu; Linda Webster; Gareth Barnes; Geoffrey Watson; Luke Howard; John Cupitt; Ian Paterson; Richard B Thompson; Kelvin Chow; Declan P O'Regan; Lan Zhao; John Wharton; David G Kiely; Adam Kinnaird; Aristeidis E Boukouris; Chris White; Jayan Nagendran; Darren H Freed; Stephen J Wort; J Simon R Gibbs; Martin R Wilkins
Journal:  Sci Transl Med       Date:  2017-10-25       Impact factor: 17.956

7.  Correlation of 18F-FLT and 18F-FDG uptake on PET with Ki-67 immunohistochemistry in non-small cell lung cancer.

Authors:  Yuka Yamamoto; Yoshihiro Nishiyama; Shinya Ishikawa; Jun Nakano; Sung Soo Chang; Shuji Bandoh; Nobuhiro Kanaji; Reiji Haba; Yoshio Kushida; Motoomi Ohkawa
Journal:  Eur J Nucl Med Mol Imaging       Date:  2007-05-26       Impact factor: 9.236

8.  A Selective Transforming Growth Factor-β Ligand Trap Attenuates Pulmonary Hypertension.

Authors:  Lai-Ming Yung; Ivana Nikolic; Samuel D Paskin-Flerlage; R Scott Pearsall; Ravindra Kumar; Paul B Yu
Journal:  Am J Respir Crit Care Med       Date:  2016-11-01       Impact factor: 21.405

9.  Heterogeneity in lung (18)FDG uptake in pulmonary arterial hypertension: potential of dynamic (18)FDG positron emission tomography with kinetic analysis as a bridging biomarker for pulmonary vascular remodeling targeted treatments.

Authors:  Lan Zhao; Ali Ashek; Lei Wang; Wei Fang; Swati Dabral; Olivier Dubois; John Cupitt; Soni Savai Pullamsetti; Emanuele Cotroneo; Hazel Jones; Gianpaolo Tomasi; Quang-De Nguyen; Eric O Aboagye; Mona A El-Bahrawy; Gareth Barnes; Luke S Howard; J Simon R Gibbs; Willy Gsell; Jian-Guo He; Martin R Wilkins
Journal:  Circulation       Date:  2013-07-30       Impact factor: 29.690

10.  Imatinib mesylate as add-on therapy for pulmonary arterial hypertension: results of the randomized IMPRES study.

Authors:  Marius M Hoeper; Robyn J Barst; Robert C Bourge; Jeremy Feldman; Adaani E Frost; Nazzareno Galié; Miguel Angel Gómez-Sánchez; Friedrich Grimminger; Ekkehard Grünig; Paul M Hassoun; Nicholas W Morrell; Andrew J Peacock; Toru Satoh; Gérald Simonneau; Victor F Tapson; Fernando Torres; David Lawrence; Deborah A Quinn; Hossein-Ardeschir Ghofrani
Journal:  Circulation       Date:  2013-02-12       Impact factor: 29.690
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.